CT

Calvin Todd Fagley

Active Director Designated Partner DIN 09408128
DIN 09408128 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Calvin Todd Fagley

Data last updated:

Calvin Todd Fagley is a Designated Partner at Vixorium International Llp (since 2021). The company operates in Healthcare.

DIN 09408128
Primary Designation Designated Partner
Industry Healthcare
First Appointment 22 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Nov 20212021Active

Board colleagues of Calvin Todd Fagley

NameDINCompanyDesignation
David James Kunelius09408129Vixorium International LlpDesignated Partner
Neeraj Gupta00037838Vixorium International LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vixorium International Llp
Premium access

Shareholding and investment profile for Calvin Todd Fagley

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Calvin Todd Fagley

Calvin Todd Fagley currently holds 1 directorship: Vixorium International Llp (Designated Partner, since 22 Nov 2021).

Calvin Todd Fagley was first appointed on 22 Nov 2021 as Designated Partner at Vixorium International Llp.

The current boards of Calvin Todd Fagley's companies include David James Kunelius (Vixorium International Llp), Neeraj Gupta (Vixorium International Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available